Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Dissection and Re-Entry Technique in Chronic Total Occlusions: Data from the PROGRESS-CTO Registry

The antegrade dissection and re-entry (ADR) technique is considered essential for the management of chronic total occlusions (CTO). It serves as the primary option in some protocols for complex and extensive lesions or as a backup strategy in case of failure with other initial strategies.

Disnea y oclusiones totales crónicas: un síntoma que podemos aliviar (o al menos intentarlo)

Dissection techniques include guided methods such as scratch and go, balloon-assisted subintimal entry (the BASE technique), the side BASE technique, the Carlino technique, and device-based strategies like Crossboss. For vessel re-entry, the guide-based methods include subintimal tracking and reentry (the STAR technique) and limited subintimal tracking (the LAST technique), as well as specific devices such as the Stingray System.

The aim of this study was to assess the frequency and outcomes of ADRs performed in the PROGRESS-CTO registry. Researchers analyzed the characteristics of patients from 46 centers, evaluating technical success (less than 30% residual stenosis) and procedural success (technical success without in-hospital major adverse cardiovascular events [MACE]).

The Registry collected data from 12,568 patients with 12,841 CTOs between 2012 and 2023. ADR was used in 18.6% of cases, with a trend to decrease over time. Patients undergoing ADR were mostly older men with dyslipidemia, peripheral arterial disease, and a family history of coronary artery disease/angioplasty or coronary bypass.

Read also: MYVAL, a TAVR Balloon-Expandable Valve with Promising Results.

ADR was chosen as the primary strategy in 17.9% of cases, as the secondary strategy in 61.3% of cases, and as a tertiary strategy in 20.8% of subjects. The right coronary artery was the most frequently treated (60.6% vs. 50.4%). Angiographically, lesions were more complex with ADR. ADR was successful in 62% of cases, and rescue with a retrograde approach was required in 45.8% of cases where ADR failed. Additionally, procedure and fluoroscopy times were longer with ADR.

Regarding in-hospital events, technical success was lower with ADR (77.0% vs. 89.3%) and so was procedural success (75.5% vs. 88.1%). Patients who underwent ADR had a higher incidence of MACE (3.7% vs. 1.6%), myocardial infarction (0.92% vs. 0.44%), and pericardiocentesis (2.01% vs. 0.67%), and higher rates of perforation (8.64% vs. 3.81%).

Conclusions

Patients treated with ADR had a higher prevalence of comorbidities and complex lesions, and a higher incidence of MACE compared with patients who received non-ADR strategies.

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the Editorial Board of SOLACI.org.

Original Title: Trends and Outcomes of Antegrade Dissection and Re-Entry in Chronic Total Occlusion Percutaneous Coronary Intervention.

Reference: Rempakos, A, Alexandrou, M, Simsek, B. et al. Trends and Outcomes of Antegrade Dissection and Re-Entry in Chronic Total Occlusion Percutaneous Coronary Intervention. J Am Coll Cardiol Intv. 2023 Nov, 16 (22) 2736–2747. https://doi.org/10.1016/j.jcin.2023.09.021.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...